Evidence map›Paper›PMID 30080869›Full record

Trial reportPloS one2018

Concordance of three alternative gestational age assessments for pregnant women from four African countries: A secondary analysis of the MIPPAD trial.

Samantha Rada, Jutta Gamper, Raquel González, Ghyslain Mombo-Ngoma, Smaïla Ouédraogo, Mwaka A Kakolwa, Rella Zoleko-Manego, Esperança Sevene, Abdunoor M Kabanywanyi, Manfred Accrombessi and 11 more

Open access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 8 institutions in 9 countries.

Samantha RadaCenter for Public Health, Department of Epidemiology, Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-5553-9191
Jutta GamperCenter for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria.
Raquel GonzálezBarcelona Centre for International Health Research, (CRESIB, Hospital Clínic-Universitat de Barcelona), ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain.
Ghyslain Mombo-NgomaCentre de Recherches Médicales de Lambaréné (CERMEL), Albert Schweitzer Hospital, Lambaréné, Gabon.
Smaïla OuédraogoFaculté des Sciences de la Santé (FSS), Université d'Aboméy Calavi, Cotonou, Benin.
Mwaka A KakolwaIfakara Health Institute (IHI), Dodoma, Tanzania.
Rella Zoleko-ManegoInstitute of Tropical Medicine, University of Tübingen, Tübingen, Germany.
Esperança SeveneManhiça Health Research Center (CISM), Manhiça, Mozambique.
Abdunoor M KabanywanyiIfakara Health Institute (IHI), Dodoma, Tanzania.
Manfred AccrombessiFaculté des Sciences de la Santé (FSS), Université d'Aboméy Calavi, Cotonou, Benin.
Valérie BriandInstitut de Recherche pour le Développement (IRD), Paris, France.
Michel CotInstitut de Recherche pour le Développement (IRD), Paris, France.
Anifa ValaManhiça Health Research Center (CISM), Manhiça, Mozambique.
Peter G KremsnerCentre de Recherches Médicales de Lambaréné (CERMEL), Albert Schweitzer Hospital, Lambaréné, Gabon.
Salim AbdullaIfakara Health Institute (IHI), Dodoma, Tanzania.
Achille MassougbodgiFaculté des Sciences de la Santé (FSS), Université d'Aboméy Calavi, Cotonou, Benin.
Arsénio NhacoloManhiça Health Research Center (CISM), Manhiça, Mozambique.
John J AponteBarcelona Centre for International Health Research, (CRESIB, Hospital Clínic-Universitat de Barcelona), ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain.
Eusébio MaceteManhiça Health Research Center (CISM), Manhiça, Mozambique.
Clara MenéndezBarcelona Centre for International Health Research, (CRESIB, Hospital Clínic-Universitat de Barcelona), ISGlobal, Barcelona Institute for Global Health, Barcelona, Spain.
Michael RamharterDepartment of Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-9259-1885
Manhiça Health Research Centre · MZAlbert Schweitzer Hospital · GAIfakara Health Institute · TZUniversité d'Abomey-Calavi · BJDélégation Paris 5 · FRCentre International de Recherches Médicales de Franceville · GAMedical University of Vienna · ATZimmer Biomet (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAt times, ultrasound is not readily available in low resource countries in Africa for accurate determination of gestational age, so using alternative methods is pivotal during pregnancy. These assessments are used to aid the risk analysis for an infant and management strategies for premature delivery, if necessary. Currently, date of last menstrual period, fundal height measurements, and the New Ballard Score are commonly used in resource-limited settings. However, concordance of these measures is unknown for sub-Saharan Africa. We obtained data from an open-label randomized controlled trial, to assess the concordance of these alternative assessment methods. The purpose of our study was to determine the agreement between these alternative methods when used in sub-Saharan African populations.

methodsA total of 4,390 pregnant women from Benin, Gabon, Mozambique and Tanzania were included in our analysis. The assessment methods compared were: 1) reported last menstrual period, 2) symphysis-fundal height measurement, and 3) the New Ballard Score. The Bland-Altman method and intraclass correlation coefficient (ICC) were used to test the degree of agreement. Survival range gestational age, used as an inclusion criterion for further analysis, was from 22 to 44 weeks.

findingsPlots showed a lack of agreement between methods and the 95% limits of agreement too wide to be clinically useful. ICC = 0.25 indicated poor agreement. A post-hoc analysis, restricted from 32 to 42 weeks, was done to check for better agreement in this near-term population. The plots and ICC = 0.16 still confirmed poor agreement.

conclusionThe alternative assessments do not result in comparable outcomes and discrepancies are far beyond the clinically acceptable range. Last menstrual period should not be used as the only estimator of gestational age. In the absence of reliable early ultrasound, symphysis-fundal height measurements may be most useful during pregnancy for fetal risk assessment and the New Ballard Score after delivery as a confirmation of these estimations and for further neonatal management. However, promotion of portable ultrasound devices is required for accurate assessment of gestational age in sub-Sahara Africa.

Indexed as

Gestational AgeUltrasonography, PrenatalAdolescentAdultBeninFemaleFetal DevelopmentGabonHumansInfant, NewbornMiddle AgedMozambiquePregnancyReproducibility of ResultsRetrospective StudiesTanzania

Identifiers

PMID30080869
PMCPMC6078285
OpenAlexW2886777840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.